CE Information - Thrombosis and Hemostasis Societies of

Thrombosis
&Hemostasis
summit2016
2016 Thrombosis & Hemostasis
Summit of North America
CE CREDITS
Sheraton Grand Chicago
Chicago, IL • April 14-16, 2016
Jointly provided by Postgraduate Institute for Medicine and
the Thrombosis and Hemostasis Societies of North America.
Thrombosis
&Hemostasis
societies
2
THSNA SOCIETIES MEMBERS AND
THSNA SUMMIT PARTNERS
athn
NASTH
North American Society on
Thrombosis & Hemostasis
™
american thrombosis
& hemostasis network
SAVE THE DATE
THSNA 2018
March 8 - 10 • San Diego, CA
THSNA 2016
TARGET AUDIENCE
This activity has been designed to meet the educational
needs of Physicians, pharmacists, registered nurses,
basic scientists, residents/fellows, technologists and allied
health professionals working in the field of thrombosis and
hemostasis.
EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better
able to:
•
Develop an appropriate treatment plan to manage
patients on newer direct oral anticoagulants (DOAC),
including how to switch between different oral
anticoagulants.
•
Identify how to measure the anticoagulant effect
of DOACs, and how and when to reverse their
anticoagulant effect.
•
Assess patients to efficiently diagnose deep vein
thrombosis (DVT) and pulmonary embolism (PE) in
both the adult and pediatric populations.
•
Develop an appropriate treatment plan for patients with
subsegmental PE and calf DVT.
•
Identify the nuances of treating superficial vein
thrombosis.
•
Initiate thrombolytic therapy in the proper situation for
both adult and pediatric patients .
•
Discuss how to treat massive DVT and PE.
•
Describe when it is appropriate to utilize IVC filters.
•
Summarize the current diagnostic and treatment
options related to abnormal bleeding in the adolescent,
reproductive and postmenopausal periods of life.
•
Discuss the preferred prevention and treatment
paradigms for massive obstetric hemorrhage in the
presence or absence of known inherited bleeding
disorders.
•
Compare the novel hemostatic agents for the care of
hemophilia.
•
Develop appropriate treatment plans to manage women
with bleeding disorders.
•
Demonstrate how to conduct common hemostasis
consults.
•
Apply an algorithmic approach in diagnosing platelet
secretion defects.
•
Discuss platelet function in regards to platelet factor 4
and the immune system.
This activity is supported by an independent educational
grant from Bayer Healthcare
APRIL 14-16, 2016 • CHICAGO, IL
TARGET AUDIENCE AND OBJECTIVES
1
2
FACULTY DIRECTORY
FACULTY DIRECTORY
Shannon Bates
McMaster University
Eric Grabowski
Harvard Medical School
Wolfgang Bergmeter
University of North Carolina
John Griffin
Scripps Research Institute
Eric Boilard
Centre Hospitalier de
l’Université Laval
Christine Guelcher
Childrens National Medical
Center
Diane Burnett
Norton Kosair Children’s
Medical Center
Sweta Gupta
Indiana Hemophilia and
Thrombosis Center
Shannon Carpenter
UMKC School of Medicine
Kristina Haley
Oregon Health & Science
University
Marc Carrier
Ottawa Hospital Research
Institute
Curtis Hanson
Mayo Clinic
Dong Chen
Mayo Clinic in Rochester
Cathy Hayward
McMaster University
Hong Chen
Boston Children’s Hospital,
Harvard Medical School
John Heit
Mayo Clinic Rochester
Jean Connors
Brigham and Women’s
Hospital
Mark Cunningham
The University of Kansas
Jorge Di Paola
University of Colorado
Kathy High
University of Pennsylvania
Steve Holly
UNC School of Medicine
Craig Hooper
Centers for Disease Control
Andra James
Duke University Medical
Center
Jim Douketis
McMaster University
Chuck Eby
Washington University
School of Medicine
Janna Journeycake
Children’s Medical Center
Dallas
Leonard Edelstein
Thomas Jefferson University
Scott Kaatz
Michigan State University
College of Human Medicine
John Fanikos
Brigham and Women’s
Hospital
Clive Kearon
McMaster University
Robert Flaumenhaft
BIDMC/Harvard Medical
School
Ken Friedman
Blood Center of Wisconsin
David Garcia
University of Washington
Bill Geerts
Sunny Brook Research
Institute
Bob Gosselin
University of California,
Davis Health System
Stephen Kingsmore
Children’s Mercy Hospitals
and Clinics
Craig Kitchens
University of Florida
Barbara Konkle
BloodWorks Institute
Peter Kouides
University of Rochester
Rebecca Kruse-Jarres
Bloodworks NW
THSNA 2016
Gregoire LeGal
Ottawa Hospital Research
Institute
Maggie Ragni
Hemophilia Center of
Western PA
Renhao Li
Emory Children’s Pediatric
Research Center
Jacob Rand
Weill Cornell Medical
College
Jennifer Maahs
Indiana Hemophilia &
Thrombosis Center
Suman Rathbun
University of Oklahoma
College of Medicine
Nigel Mackman
University of North Carolina
Mark Reding
University of Minnesota
Richard Marlar
University of Oklahoma
College of Medicine
Terri Schnurr
St. Joseph’s Healthcare
Kimberly Martinod
Harvard Medical School
Rita Selby
Sunnybrook Health
Sciences Centre
Alan Michelson
Harvard Medical School
Robert Sidonio
Emory University
Stephan Moll
University of North Carolina
School of Medicine
Susan Stramer
American Red Cross
Craig Morrell
University of Rochester
Tim Morris
UC San Diego Health
System
James Munn
University of Michigan
Cindy Neunert
Georgia Regents University
Heyu Ni
University of Toronto
Diane Nugent
Children’s Hospital of
Orange County
Sarah O’Brien
The Research Institute
at Nationwide Children’s
Hospital
Anand Padmanabhan
BloodCenter of Wisconsin
Michael Paidas
Yale School of Medicine
Rajiv Pruthi
Mayo Clinic
Ed Pryzdial
University of British
Columbia
Bruce Sullenger
Duke University
Suresh Vedantham
Washington University
Ted Warkentin
McMaster University
Hartmut Weiler
Blood Center of Wisconsin
Jeff Weitz
McMaster University
Sidney Whiteheart
University of Kentucky
Annie Winkler
Emory University School of
Medicine
Char Witmer
Children’s Hospital of
Philadelphia
Alisa Wolberg
University of North Carolina
at Chapel Hill
Guy Young
Children’s Hospital Los
Angeles
Jim Zehnder
Stanford University School
of Medicine
Leslie Raffini
Children’s Hospital of
Philiadelphia, University of
Pennsylvania
APRIL 14-16, 2016 • CHICAGO, IL
FACULTY DIRECTORY
3
4
CREDIT INFORMATION
PHYSICIAN CONTINUING MEDICAL
EDUCATION
Accreditation Statement
This activity has been planned and implemented in
accordance with the accreditation requirements and policies
of the Accreditation Council for Continuing Medical Education
(ACCME) through the joint providership of Postgraduate
Institute for Medicine and the Thrombosis and Hemostasis
Society of North America. The Postgraduate Institute for
Medicine is accredited by the ACCME to provide continuing
medical education for physicians.
Credit Designation
The Postgraduate Institute for Medicine designates this
live activity for a maximum of 19.25 AMA PRA Category
1 Credit(s)™. Physicians should claim only the credit
commensurate with the extent of their participation in the
activity.
PHARMACIST CONTINUING
EDUCATION
Accreditation Statement
Postgraduate Institute for Medicine is
accredited by the Accreditation Council
for Pharmacy Education as a provider of
continuing pharmacy education.
Credit Designation
Postgraduate Institute for Medicine designates this continuing
education activity for 19.25 contact hour(s) (0.1925 CEUs) of
the Accreditation Council for Pharmacy Education.
Universal Activity Numbers:
0809-9999-16-129-L01-P
0809-9999-16-096-L01-P
0809-9999-16-097-L01-P
0809-9999-16-098-L01-P
0809-9999-16-099-L01-P
0809-9999-16-100-L01-P
0809-9999-16-101-L01-P
0809-9999-16-102-L01-P
0809-9999-16-103-L01-P
0809-9999-16-104-L01-P
0809-9999-16-105-L01-P
0809-9999-16-106-L01-P
0809-9999-16-107-L01-P
0809-9999-16-108-L01-P
0809-9999-16-109-L01-P
0809-9999-16-110-L01-P
0809-9999-16-111-L01-P
0809-9999-16-112-L01-P
0809-9999-16-113-L01-P
0809-9999-16-124-L01-P
0809-9999-16-114-L01-P
0809-9999-16-115-L01-P
0809-9999-16-117-L01-P
0809-9999-16-118-L01-P
Type of Activity: Application
Fee Information
There is no fee for this educational activity.
NURSING CONTINUING
EDUCATION
Credit Designation
This educational activity for 21.25 contact hours is provided
by Postgraduate Institute for Medicine.
Accreditation Statements
Postgraduate Institute for Medicine is accredited as a provider
of continuing nursing education by the American Nurses
Credentialing Center’s Commission on Accreditation.
THSNA 2016
ASCLS P.A.C.E. ® CREDITS
Accreditation Statement
Postgraduate Institute for Medicine is approved as a provider
of continuing education programs in the clinical laboratory
sciences by the ASCLS P.A.C.E. ® Program.
DISCLOSURE OF CONFLICTS OF
INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors,
planners, managers and other individuals who are in a position
to control the content of this activity to disclose any real or
apparent conflict of interest (COI) they may have as related
to the content of this activity. All identified COI are thoroughly
vetted and resolved according to PIM policy. PIM is committed
to providing its learners with high quality CME activities and
related materials that promote improvements or quality in
healthcare and not a specific proprietary business interest of a
commercial interest.
The faculty reported the following financial relationships
or relationships they or their spouse/life partner have with
commercial interests related to the content of this continuing
education activity:
Diane Burnett: Board/Committee Membership/Advisory Board
(Biogen)
Marc Carrier: Grant/Research Support (BMS, LEO Pharma),
Honorarium/Expenses (Pfizer, Bayer, Sanofi, BI, Leo Pharma)
Jean Connors: Board/Committee Membership/Advisory Board
(Boehringer-Ingelheim), Honorarium/Expenses (Bristol-Meyer
Squibb)
Jim Douketis: Grant/Research Support (BoehringerIngelheim), Consultant Fee (Janssen Pharmaceuticals),
Board/Committee Membership/Advisory Board (Bayer, Sanofi,
Boehringer-Ingelheim, Pfizer, Daiichi-Sankyo)
Chuck Eby: Grant/Research Support (Siemens Diagnostics,
Arkray USA), Board/Committee Membership/Advisory Board (
Instrumentation Laboratory,Novo Nordisk,CAP)
John Fanikos: Board/Committee Membership/Advisory Board
(Boehringer-Ingelheim, BD Rx, Inc)
David Garcia: Grant/Research Support (Janssen, Bayer,
Daiichi Sankyo), Honorarium/Expenses (BMS, Pfizer,
Boehringer Ingelheim, Janssen)
Bob Gosselin: Consultant Fee (NovoNordisk, Boehinger
Ingelheim, Sekisui Diagnostics), Board/Committee
Membership/Advisory Board (Instrumentation Laboratory)
Eric Grabowski: Grant/Research Support (Novo Nordisk,
CSL Behring), Board/Committee Membership/Advisory Board
(CSL Behring, Momenta, Emergent Biosolutions), Honorarium/
Expenses (CSL Behring, Momenta, Emergent Biosolutions)
Christine Guelcher: Board/Committee Membership/Advisory
Board (Biogen, Baxalta, Novo Nordisk, Octapharma, Grifols),
Honorarium/Expenses (NHF, Solultion Sight)
Kristina Haley: Honorarium/Expenses (Baxalta, CSL Behring)
Kathy High: Consultant Fee (Spark Therapeutic,; spouse of
an employee of Pfizer, Inc.), Board/Committee Membership/
Advisory Board (Spark therapeutics), Stocks/Bonds (Spark
Therapeutics), Intellectual Property/Royalty Income ( Spark)
APRIL 14-16, 2016 • CHICAGO, IL
FACULTY DISCLOSURES
5
6
FACULTY DISCLOSURES
Andra James: Honorarium/Expenses (Baxalta)
Scott Kaatz: Board/Committee Membership/Advisory Board
(Janssen, Boehringer-Ingelheim, Bristol Myer Squibb/Pfizer,
CSL Behring, Daiichi Sankyo, Portola), Stocks/Bonds (Janssen,
Boehringer-Ingelheim, Bristol Myer Squibb/Pfizer, CSL Behring,
Daiichi Sankyo)
Stephen Kingsmore: Grant/Research Support (Illumina inc.),
Board/Committee Membership/Advisory Board (Edico genomics,
Parabase Genomics), Stocks/Bonds (Edico Genomics,
Parabase Genomics), Honorarium/Expenses (Vermont Oxford
Network), Intellectual Property/Royalty Income (Children’s Mercy
Hospital)
Barbara Konkle: Grant/Research Support
(Baxalta,Octapharma), Consultant Fee (CSL Behring, Baxalta)
Rebecca Kruse-Jarres: Grant/Research Support
(Roche,Genentech, Baxalta), Consultant Fee (Baxalta, Bayer,
CSL Behring, Grifols, NovoNordisk, Pfizer, Roche), Board/
Committee Membership/Advisory Board (Baxalta, Bayer, CSL
Behring, NovoNordisk, Roche, Pfizer), Honorarium/Expenses (Baxalta, Bayer, CSL Behring, NovoNordisk, Roche, Pfizer)
Alan Michelson: Grant/Research Support (GLSynthesis,
Lilly, Sysmex), Board/Committee Membership/Advisory Board
(AstraZeneca, Lilly)
Stephan Moll: Consultant Fee (Boehringer-Ingelheim)
Tim Morris: Grant/Research Support (Bayer)
James Munn: Consultant Fee (Bayer - consultant), Board/
Committee Membership/Advisory Board (Baxalta,BiogenIdec,CSL Behring,Emergent BioSolutions,NovoNordisk)
Sarah O’Brien: Grant/Research Support (Bristol Myers Squibb),
Board/Committee Membership/Advisory Board (Pfizer)
Anand Padmanabhan: Intellectual Property/Royalty Income
(BloodCenter of Wisconsin)
Michael Paidas: Grant/Research Support (rEVO Biologics)
Leslie Raffini: Board/Committee Membership/Advisory Board
(Bayer, CSL Behring, Drug Safety Solutions, Basalt)
Maggie Ragni: Grant/Research Support (Alnylam), Honorarium/
Expenses (Alnylam)
Mark Reding: Grant/Research Support (Bayer), Board/
Committee Membership/Advisory Board (Bayer, Baxalta, Biogen,
Novo Nordisk), Honorarium/Expenses (Bayer, Baxalta, Biogen,
Novo Nordisk, Pfizer)
Bruce Sullenger: Stocks/Bonds (Regado Biosciences),
Intellectual Property/Royalty Income (Regado Biosciences)
Suresh Vedantham: Grant/Research Support (Genentech, BSN
Medical)
Ted Warkentin: Grant/Research Support (Instrumentation
Laboratory, WL Gore), Consultant Fee (Aspen Global; WL
Gore; medical-legal testimony), Board/Committee Membership/
Advisory Board (Instrumentation Laboratory)
Jeff Weitz: Honorarium/Expenses (Boehringer Ingelheim,
Bayer, Pfizer, Bristol Myers Squibb, Daiichi-Sankyo, Merck,
Portola, Ionis, Janssen)
Guy Young: Board/Committee Membership/Advisory Board
(Biogen, Baxalta, Novo Nordisk), Honorarium/Expenses (Biogen, Baxalta, Novo Nordisk)
THSNA 2016
Jim Zehnder: Board/Committee Membership/Advisory Board
(Novo Nordisk, Instrumentation Laboratories, Novartis)
The following faculty reported no financial relationships
or relationships they or their spouse/life partner have with
commercial interests related to the content of this continuing
education activity:
Shannon Bates, Wolfgang Bergmeter, Eric Boilard, Shannon
Carpenter, Dong Chen, Hong Chen, Mark Cunningham,
Jorge Di Paola, Leonard Edelstein, Robert Flaumenhaft,
Ken Friedman, Bill Geerts, John Griffin, Sweta Gupta, Curtis
Hanson, Cathy Hayward, John Heit, Steve Holly, Craig
Hooper, Janna Journeycake, Clive Kearon, Craig Kitchens,
Peter Kouides, Gregoire LeGal, Renhao Li, Jennifer Maahs,
Nigel Mackman, Richard Marlar, Kimberly Martinod, Craig
Morrell, Cindy Neunert, Heyu Ni, Diane Nugent, Rajiv Pruthi,
Ed Pryzdial, Jacob Rand, Suman Rathbun, Terri Schnurr,
Rita Selby, Robert Sidonio, Susan Stramer, Elizabeth Van
Cott, Hartmut Weiler, Sidney Whiteheart, Annie Winkler, Char
Witmer, Daniel Witt, Alisa Wolberg
The planners and managers reported the following financial
relationships or relationships they or their spouse/life partner
have with commercial interests related to the content of this
continuing education activity:
The following PIM planners and managers, Judi SmelkerMitchek, RN, BSN, Trace Hutchison, PharmD, Samantha
Mattiucci, PharmD, CHCP, and Jan Schultz, MSN, RN, CHCP,
hereby state that they or their spouse/life partner do not have
any financial relationships or relationships to products or
devices with any commercial interest related to the content of
this activity of any amount during the past 12 months.
The following THSNA and SPLtrak planners and managers,
Adam Kohm, PhD, Lorena Castaneda and Melissa
Szkodzinska, hereby state that they or their spouse/life partner
do not have any financial relationships or relationships to
products or devices with any commercial interest related to
the content of this activity of any amount during the past 12
months.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published
and/or investigational uses of agents that are not indicated by
the FDA. The planners of this activity do not recommend the
use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of
the faculty and do not necessarily represent the views of the
planners. Please refer to the official prescribing information
for each product for discussion of approved indications,
contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly
acquired information to enhance patient outcomes and their
own professional development. The information presented in
this activity is not meant to serve as a guideline for patient
management. Any procedures, medications, or other courses
of diagnosis or treatment discussed or suggested in this
activity should not be used by clinicians without evaluation of
their patient’s conditions and possible contraindications and/
or dangers in use, review of any applicable manufacturer’s
product information, and comparison with recommendations of
other authorities.
APRIL 14-16, 2016 • CHICAGO, IL
FACULTY DISCLOSURES/DISCLAIMER
7
8
CERTIFICATES
HOW TO OBTAIN YOUR CME OR CE
CERTIFICATE
PIM supports Green CME by offering your Request for Credit
online. If you wish to receive acknowledgment for completing
this activity, please follow the steps below:
1.
2.
3.
4.
5.
Go to CME University at: www.cmeuniversity.com and
register or login
Once logged in, click on “Find Post-test/Evaluation by
Course” at the top of the page
Type in “11408” in the box, and hit enter
Click on the session title
Complete the online evaluation form and obtain your
CME certificate to download and/or print for your files.
For Pharmacists: Upon completion of the online activity
evaluation form(s), transcript information will be sent to the
NABP CPE Monitor Service.
Upon completion of the online posttest and evaluation form,
you will have immediate access to a certificate of attendance
to print or save for your files. You can save your certificate by
selecting the “Save” option on the print screen.
For any questions relating certification for this activity, please
contact Postgraduate Institute for Medicine at: information@
pimed.com or (303) 799-1930.
THSNA 2016
9
Thrombosis
&Hemostasis
societies
APRIL 14-16, 2016 • CHICAGO, IL
10
THSNA 2016